Tech Company Financing Transactions

Sirtris Pharmaceuticals Funding Round

Sirtris Pharmaceuticals, operating out of Cambridge, raised $27 million in funding from Cardinal Partners, Cargill Ventures and Covera Ventures.

Transaction Overview

Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
200 Technology Square 300
Cambridge, MA 02139
USA
Email Address
Overview
Sirtris Pharmaceuticals is a biopharmaceutical company developing and commercializing novel therapeutics that modulate sirtuins, a recently discovered family of enzymes that promotes the body's natural defense against disease. Also known as class III histone deacetylases (HDACs), sirtuins are attractive drug targets for diseases of aging, including metabolic and neurological diseases.
Profile
Sirtris Pharmaceuticals LinkedIn Company Profile
Social Media
Sirtris Pharmaceuticals Company Twitter Account
Company News
Sirtris Pharmaceuticals News
Facebook
Sirtris Pharmaceuticals on Facebook
YouTube
Sirtris Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christoph Westphal
  Christoph Westphal LinkedIn Profile  Christoph Westphal Twitter Account  Christoph Westphal News  Christoph Westphal on Facebook
Chief Operating Officer
Garen Bohlin
  Garen Bohlin LinkedIn Profile  Garen Bohlin Twitter Account  Garen Bohlin News  Garen Bohlin on Facebook
Vice President
Peter Elliott
  Peter Elliott LinkedIn Profile  Peter Elliott Twitter Account  Peter Elliott News  Peter Elliott on Facebook
VP - Finance
Paul Brannelly
  Paul Brannelly LinkedIn Profile  Paul Brannelly Twitter Account  Paul Brannelly News  Paul Brannelly on Facebook
VP - R & D
Michael Jirousek
  Michael Jirousek LinkedIn Profile  Michael Jirousek Twitter Account  Michael Jirousek News  Michael Jirousek on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2005: IntelliDx venture capital transaction
Next: 3/31/2005: Biolex venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary